Abstract |
Despite aggressive surgery, radiotherapy, and chemotherapy, treatment of malignant glioma remains formidable. Although the concept of cancer stem cells reveals a new framework of cancer therapeutic strategies against malignant glioma, it remains unclear how glioma stem cells could be eradicated. Here, we demonstrate that autocrine TGF-beta signaling plays an essential role in retention of stemness of glioma-initiating cells (GICs) and describe the underlying mechanism for it. TGF-beta induced [corrected] expression of Sox2, a stemness gene, and this induction was mediated by Sox4, a direct TGF-beta target gene. Inhibitors of TGF-beta signaling drastically deprived tumorigenicity of GICs by promoting their differentiation, and these effects were attenuated in GICs transduced with Sox2 or Sox4. Furthermore, GICs pretreated with TGF-beta signaling inhibitor exhibited less lethal potency in intracranial transplantation assay. These results identify an essential pathway for GICs, the TGF-beta-Sox4-Sox2 pathway, whose disruption would be a therapeutic strategy against gliomas.
|
Authors | Hiroaki Ikushima, Tomoki Todo, Yasushi Ino, Masamichi Takahashi, Keiji Miyazawa, Kohei Miyazono |
Journal | Cell stem cell
(Cell Stem Cell)
Vol. 5
Issue 5
Pg. 504-14
(Nov 06 2009)
ISSN: 1875-9777 [Electronic] United States |
PMID | 19896441
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide
- Benzamides
- Dioxoles
- Receptors, Transforming Growth Factor beta
- SOX Transcription Factors
- SOX2 protein, human
- SOX4 protein, human
- SOXB1 Transcription Factors
- SOXC Transcription Factors
- Transforming Growth Factor beta
|
Topics |
- Aged
- Animals
- Benzamides
(pharmacology)
- Brain Neoplasms
(genetics, metabolism, pathology)
- Cell Differentiation
- Cells, Cultured
- Dioxoles
(pharmacology)
- Female
- Glioblastoma
(genetics, metabolism, pathology)
- Humans
- Male
- Mice
- Mice, Nude
- Middle Aged
- Neoplasm Transplantation
- Neoplastic Stem Cells
(metabolism, pathology)
- Receptors, Transforming Growth Factor beta
(antagonists & inhibitors)
- SOX Transcription Factors
(metabolism)
- SOXB1 Transcription Factors
(genetics, metabolism)
- SOXC Transcription Factors
- Signal Transduction
- Transforming Growth Factor beta
(pharmacology)
|